In patients with schizophrenia, there appear to be connections between longer duration of illness, raised levels of eotaxin, decreased telomere length, reduced gray matter volume, and impaired episodic memory.
Related content
The Use of Virtual Reality in the Treatment of Severe Mental Illnesses: The Example of Psychosis
The use of virtual reality in the treatment of severe mental illnesses
02.10.2024
Schizophrenia
Diagnostic Challenges in Bipolar Disorder: Depression, Mania, and Schizophrenia
In this video, Professors Lakshmi Yatham, MD., and Christoph Correll, MD. discuss the challenges of differentiating bipolar disorder.
03.09.2024
Bipolar Disorder
Novel and emerging pharmacologic treatments for Schizophrenia
In this video Professor Christoph Correll discusses the challenges with available schizophrenia treatments & what clinicians should keep in mind when considering the emerging treatment options for schizophrenia.
14.11.2023
Schizophrenia